凱杰生物QGEN
紐約證券 · USD
55.62
+1.37
(+2.53%)
收盤 01/24 04:59 (UTC+8)
01/24 04:59 (UTC+8)
凱杰生物QGEN
55.62
+1.37
(+2.53%)
財務數據
損益表
- 4.95
- 4.76
- 5.09
- 4.59
- 4.96
- 5.02
- 5.21
- 4.83
- 5.34
- 5.33
- 1.95
- -3.83
- 6.99
- -9.89
- 8.18
- 1.11
- 3.85
- -7.24
- 10.36
- -0.18
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 532,583 | 533,540 | 483,456 | 521,202 | 501,869 | 496,347 | 458,796 | 509,162 | 475,894 | 494,857 |
營業成本 | 201,324 | 199,254 | 174,775 | 187,912 | 193,562 | 461,583 | 167,807 | 193,062 | 177,934 | 182,705 |
營業毛利 | 331,259 | 334,286 | 308,681 | 333,290 | 308,307 | 34,764 | 290,989 | 316,100 | 297,960 | 312,152 |
營業費用 | 193,966 | 198,312 | 183,518 | 192,126 | 187,460 | 195,121 | 192,744 | 194,610 | 190,758 | 198,118 |
研發費用 | 48,748 | 47,750 | 43,783 | 48,605 | 44,453 | 49,103 | 51,333 | 45,966 | 47,934 | 49,893 |
推銷及管理費用 | 143,106 | 148,745 | 137,942 | 141,712 | 140,656 | 143,304 | 138,689 | 145,952 | 140,111 | 145,523 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 137,293 | 135,974 | 125,163 | 141,164 | 120,847 | -160,357 | 98,245 | 121,490 | 107,202 | 114,034 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 8,218 | 7,605 | 7,294 | 11,143 | 11,484 | 10,922 | 10,292 | 12,441 | 13,018 | 13,497 |
稅前純益 | 134,726 | 126,821 | 119,549 | 125,852 | 116,456 | -223,451 | 102,290 | 118,876 | 99,830 | 102,316 |
所得稅 | 4,683 | 30,571 | 28,791 | 37,530 | 18,400 | -39,991 | 21,617 | 21,212 | 22,012 | 21,530 |
稅後純益 | 130,043 | 96,250 | 90,758 | 88,322 | 98,056 | -183,460 | 80,673 | 97,664 | 77,818 | 80,786 |
基本每股稅後盈餘(元) | 0.60 | 0.44 | 0.42 | 0.40 | 0.43 | -0.81 | 0.35 | 0.43 | 0.33 | 0.35 |
稀釋每股稅後盈餘(元) | 0.60 | 0.44 | 0.41 | 0.39 | 0.43 | -0.81 | 0.35 | 0.42 | 0.33 | 0.35 |
基本平均股數(千股) | 216871.00 | 216702.00 | 218377.00 | 222290.00 | 228665.00 | 228331.00 | 230230.00 | 228202.00 | 235317.00 | 228182.00 |
稀釋平均股數(千股) | 218453.00 | 218183.00 | 220189.00 | 224245.00 | 230436.00 | 228331.00 | 233045.00 | 230745.00 | 237745.00 | 230517.00 |
還原基本每股稅後盈餘(元) | 0.63 | 0.46 | 0.44 | 0.43 | 0.46 | -0.87 | 0.38 | 0.48 | 0.37 | 0.40 |
還原稀釋每股稅後盈餘(元) | 0.63 | 0.46 | 0.43 | 0.42 | 0.46 | -0.87 | 0.38 | 0.47 | 0.37 | 0.39 |
還原基本平均股數(千股) | 206,027 | 205,866 | 207,458 | 205,309 | 211,198 | 210,889 | 212,643 | 204,447 | 210,821 | 204,428 |
還原稀釋平均股數(千股) | 207,530 | 207,273 | 209,179 | 207,115 | 212,833 | 210,889 | 215,243 | 206,725 | 212,996 | 206,520 |
EBITDA(千元) | 193,910 | 183,904 | 170,751 | 182,547 | 177,933 | -159,136 | 166,912 | 182,887 | 163,417 | 166,949 |